Concepts (225)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Bladder, Overactive | 8 | 2024 | 90 | 3.370 |
Why?
|
| Suburethral Slings | 5 | 2020 | 77 | 2.660 |
Why?
|
| Urinary Incontinence | 4 | 2023 | 214 | 2.140 |
Why?
|
| Urologic Surgical Procedures | 7 | 2024 | 149 | 2.080 |
Why?
|
| Urology | 4 | 2024 | 121 | 2.040 |
Why?
|
| Lower Urinary Tract Symptoms | 4 | 2022 | 70 | 2.040 |
Why?
|
| Urinary Incontinence, Stress | 5 | 2017 | 198 | 1.580 |
Why?
|
| Urinary Bladder Neck Obstruction | 3 | 2022 | 21 | 1.560 |
Why?
|
| Prostatic Hyperplasia | 4 | 2016 | 90 | 1.560 |
Why?
|
| Laser Therapy | 4 | 2016 | 148 | 1.520 |
Why?
|
| Social Media | 2 | 2023 | 96 | 1.370 |
Why?
|
| Postoperative Complications | 8 | 2024 | 2314 | 1.310 |
Why?
|
| Urodynamics | 5 | 2022 | 123 | 1.240 |
Why?
|
| Diabetes Complications | 2 | 2020 | 171 | 1.240 |
Why?
|
| Prostatectomy | 4 | 2016 | 476 | 1.170 |
Why?
|
| Prostatism | 3 | 2010 | 5 | 1.070 |
Why?
|
| Thulium | 2 | 2016 | 2 | 1.020 |
Why?
|
| Lasers, Solid-State | 2 | 2016 | 8 | 1.010 |
Why?
|
| Pelvic Organ Prolapse | 4 | 2023 | 162 | 0.980 |
Why?
|
| Uterine Prolapse | 3 | 2023 | 82 | 0.940 |
Why?
|
| Urinary Bladder | 4 | 2022 | 248 | 0.900 |
Why?
|
| Transurethral Resection of Prostate | 3 | 2014 | 10 | 0.900 |
Why?
|
| Surgery, Plastic | 1 | 2023 | 42 | 0.850 |
Why?
|
| Cystitis, Interstitial | 1 | 2023 | 53 | 0.830 |
Why?
|
| Nocturia | 1 | 2022 | 19 | 0.830 |
Why?
|
| Electric Stimulation Therapy | 1 | 2022 | 47 | 0.780 |
Why?
|
| Spinal Cord Injuries | 1 | 2022 | 64 | 0.770 |
Why?
|
| Muscarinic Antagonists | 3 | 2010 | 59 | 0.740 |
Why?
|
| Urinary Tract Infections | 5 | 2022 | 76 | 0.720 |
Why?
|
| Vagina | 3 | 2022 | 177 | 0.710 |
Why?
|
| Phenylpropanolamine | 2 | 2010 | 15 | 0.680 |
Why?
|
| Cresols | 2 | 2010 | 17 | 0.680 |
Why?
|
| Comprehension | 1 | 2020 | 81 | 0.680 |
Why?
|
| Hysterectomy | 2 | 2022 | 156 | 0.680 |
Why?
|
| Benzhydryl Compounds | 2 | 2010 | 44 | 0.670 |
Why?
|
| Video Recording | 1 | 2020 | 203 | 0.650 |
Why?
|
| Smoking | 5 | 2007 | 625 | 0.640 |
Why?
|
| Humans | 53 | 2024 | 89985 | 0.640 |
Why?
|
| Female | 34 | 2024 | 46602 | 0.630 |
Why?
|
| Spinal Dysraphism | 1 | 2018 | 19 | 0.630 |
Why?
|
| Middle Aged | 28 | 2024 | 26159 | 0.630 |
Why?
|
| Urinary Bladder, Neurogenic | 1 | 2018 | 25 | 0.620 |
Why?
|
| Urinary Bladder Diseases | 1 | 2017 | 41 | 0.570 |
Why?
|
| Cystocele | 1 | 2017 | 7 | 0.570 |
Why?
|
| Surgical Mesh | 2 | 2022 | 124 | 0.570 |
Why?
|
| Patient Education as Topic | 1 | 2020 | 365 | 0.560 |
Why?
|
| Aged | 20 | 2022 | 19262 | 0.560 |
Why?
|
| Vesicovaginal Fistula | 1 | 2016 | 12 | 0.550 |
Why?
|
| Cystectomy | 1 | 2017 | 106 | 0.540 |
Why?
|
| Internship and Residency | 2 | 2023 | 1063 | 0.520 |
Why?
|
| Retrospective Studies | 11 | 2022 | 9216 | 0.520 |
Why?
|
| Gynecology | 1 | 2017 | 130 | 0.500 |
Why?
|
| Alcoholism | 5 | 2005 | 180 | 0.480 |
Why?
|
| Databases, Factual | 4 | 2020 | 866 | 0.460 |
Why?
|
| Azasteroids | 2 | 2012 | 5 | 0.450 |
Why?
|
| Adult | 24 | 2024 | 26827 | 0.440 |
Why?
|
| Male | 29 | 2024 | 42690 | 0.430 |
Why?
|
| Ethanol | 6 | 2006 | 253 | 0.420 |
Why?
|
| Treatment Outcome | 8 | 2022 | 8277 | 0.390 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2017 | 608 | 0.390 |
Why?
|
| Naltrexone | 3 | 2004 | 138 | 0.380 |
Why?
|
| Urination | 3 | 2016 | 38 | 0.380 |
Why?
|
| United States | 5 | 2024 | 7114 | 0.360 |
Why?
|
| Prostate | 3 | 2012 | 407 | 0.360 |
Why?
|
| Surveys and Questionnaires | 5 | 2024 | 2657 | 0.360 |
Why?
|
| Urethral Diseases | 1 | 2010 | 15 | 0.350 |
Why?
|
| Alcohol Drinking | 5 | 2006 | 275 | 0.350 |
Why?
|
| Diverticulum | 1 | 2010 | 45 | 0.340 |
Why?
|
| Diagnostic Errors | 1 | 2010 | 160 | 0.320 |
Why?
|
| Smoking Cessation | 3 | 2007 | 258 | 0.310 |
Why?
|
| Anticoagulants | 1 | 2011 | 432 | 0.300 |
Why?
|
| Operative Time | 2 | 2018 | 147 | 0.280 |
Why?
|
| Case-Control Studies | 2 | 2022 | 1866 | 0.270 |
Why?
|
| Quality of Life | 3 | 2022 | 1682 | 0.270 |
Why?
|
| Research Subjects | 1 | 2017 | 73 | 0.270 |
Why?
|
| Substance Abuse Treatment Centers | 2 | 2004 | 24 | 0.250 |
Why?
|
| Hydrocortisone | 4 | 2005 | 301 | 0.250 |
Why?
|
| Gynecologic Surgical Procedures | 2 | 2017 | 157 | 0.250 |
Why?
|
| Behavior, Addictive | 1 | 2017 | 134 | 0.240 |
Why?
|
| Comorbidity | 2 | 2020 | 953 | 0.240 |
Why?
|
| Urologists | 1 | 2024 | 29 | 0.230 |
Why?
|
| Organ Size | 3 | 2016 | 372 | 0.230 |
Why?
|
| Patient Dropouts | 1 | 2004 | 30 | 0.230 |
Why?
|
| Education, Medical, Graduate | 2 | 2023 | 403 | 0.230 |
Why?
|
| Self-Help Groups | 1 | 2023 | 14 | 0.220 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 1082 | 0.220 |
Why?
|
| Aged, 80 and over | 5 | 2020 | 6785 | 0.210 |
Why?
|
| Patient Selection | 1 | 2017 | 682 | 0.210 |
Why?
|
| Stress, Psychological | 3 | 2005 | 322 | 0.210 |
Why?
|
| Pelvic Floor Disorders | 1 | 2023 | 56 | 0.210 |
Why?
|
| Biomedical Research | 1 | 2017 | 405 | 0.200 |
Why?
|
| Sacrococcygeal Region | 1 | 2022 | 9 | 0.200 |
Why?
|
| Tibial Nerve | 1 | 2022 | 14 | 0.200 |
Why?
|
| Placenta Accreta | 1 | 2022 | 8 | 0.200 |
Why?
|
| Balloon Occlusion | 1 | 2022 | 29 | 0.200 |
Why?
|
| Urinary Retention | 1 | 2022 | 42 | 0.200 |
Why?
|
| Child | 2 | 2023 | 7242 | 0.190 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2022 | 50 | 0.190 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 3678 | 0.190 |
Why?
|
| Prostate-Specific Antigen | 2 | 2014 | 341 | 0.180 |
Why?
|
| Urethral Stricture | 1 | 2020 | 14 | 0.180 |
Why?
|
| Crohn Disease | 1 | 2007 | 764 | 0.180 |
Why?
|
| Prospective Studies | 6 | 2022 | 4329 | 0.180 |
Why?
|
| Risk Factors | 4 | 2017 | 5562 | 0.170 |
Why?
|
| Colitis, Ulcerative | 1 | 2007 | 760 | 0.170 |
Why?
|
| Tolterodine Tartrate | 2 | 2010 | 15 | 0.170 |
Why?
|
| Surgeons | 1 | 2024 | 249 | 0.170 |
Why?
|
| Substance-Related Disorders | 1 | 2004 | 421 | 0.170 |
Why?
|
| Urethra | 1 | 2020 | 116 | 0.170 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 983 | 0.160 |
Why?
|
| Surgical Flaps | 2 | 2020 | 250 | 0.150 |
Why?
|
| Education | 1 | 2018 | 58 | 0.150 |
Why?
|
| Urinary Catheterization | 1 | 2018 | 36 | 0.150 |
Why?
|
| Medical Overuse | 1 | 2018 | 36 | 0.150 |
Why?
|
| Hospitals, Teaching | 1 | 2018 | 118 | 0.150 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 3477 | 0.150 |
Why?
|
| Pilot Projects | 1 | 2020 | 872 | 0.150 |
Why?
|
| Specimen Handling | 1 | 2018 | 103 | 0.140 |
Why?
|
| Incontinence Pads | 1 | 2016 | 4 | 0.130 |
Why?
|
| Temperance | 2 | 2003 | 6 | 0.130 |
Why?
|
| Blood Transfusion | 1 | 2016 | 171 | 0.130 |
Why?
|
| Tobacco Use Disorder | 1 | 2006 | 116 | 0.120 |
Why?
|
| Cues | 1 | 2006 | 174 | 0.120 |
Why?
|
| Central Nervous System Depressants | 1 | 2005 | 45 | 0.120 |
Why?
|
| Volatilization | 1 | 2014 | 6 | 0.120 |
Why?
|
| Prosthesis Implantation | 1 | 2016 | 129 | 0.120 |
Why?
|
| Quality Improvement | 1 | 2018 | 457 | 0.120 |
Why?
|
| Dutasteride | 2 | 2012 | 5 | 0.110 |
Why?
|
| Pursuit, Smooth | 1 | 2004 | 31 | 0.110 |
Why?
|
| Heart Diseases | 1 | 2016 | 302 | 0.110 |
Why?
|
| Safety | 1 | 2014 | 145 | 0.110 |
Why?
|
| Saccades | 1 | 2004 | 68 | 0.110 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2003 | 47 | 0.110 |
Why?
|
| Length of Stay | 1 | 2017 | 749 | 0.110 |
Why?
|
| Affect | 2 | 2003 | 389 | 0.110 |
Why?
|
| Incidence | 1 | 2017 | 1604 | 0.110 |
Why?
|
| Life Change Events | 1 | 2003 | 48 | 0.100 |
Why?
|
| Finasteride | 1 | 2012 | 8 | 0.100 |
Why?
|
| Clinical Competence | 1 | 2018 | 797 | 0.100 |
Why?
|
| 5-alpha Reductase Inhibitors | 1 | 2012 | 12 | 0.100 |
Why?
|
| Pituitary-Adrenal System | 1 | 2002 | 64 | 0.100 |
Why?
|
| Obesity, Abdominal | 1 | 2012 | 8 | 0.100 |
Why?
|
| Waist Circumference | 1 | 2012 | 22 | 0.100 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2002 | 81 | 0.100 |
Why?
|
| Stress, Physiological | 1 | 2003 | 232 | 0.100 |
Why?
|
| Cohort Studies | 2 | 2018 | 2886 | 0.100 |
Why?
|
| Personality | 1 | 2003 | 136 | 0.090 |
Why?
|
| Analysis of Variance | 4 | 2004 | 899 | 0.090 |
Why?
|
| Metabolic Syndrome | 1 | 2012 | 123 | 0.090 |
Why?
|
| Cholestenone 5 alpha-Reductase | 1 | 2010 | 2 | 0.090 |
Why?
|
| Narcotic Antagonists | 1 | 2002 | 162 | 0.090 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2010 | 36 | 0.090 |
Why?
|
| Psychomotor Performance | 1 | 2004 | 497 | 0.090 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2010 | 32 | 0.090 |
Why?
|
| Cognition Disorders | 1 | 2002 | 233 | 0.090 |
Why?
|
| Sex Characteristics | 1 | 2003 | 328 | 0.090 |
Why?
|
| Delayed-Action Preparations | 1 | 2010 | 110 | 0.080 |
Why?
|
| Risk Assessment | 1 | 2017 | 2327 | 0.080 |
Why?
|
| Motivation | 2 | 2017 | 296 | 0.080 |
Why?
|
| Double-Blind Method | 3 | 2005 | 1714 | 0.080 |
Why?
|
| Young Adult | 2 | 2018 | 6415 | 0.080 |
Why?
|
| Drug Therapy, Combination | 1 | 2010 | 785 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 1181 | 0.080 |
Why?
|
| Drug Administration Schedule | 1 | 2009 | 864 | 0.070 |
Why?
|
| Biomarkers | 1 | 2014 | 1778 | 0.070 |
Why?
|
| Hypertension | 1 | 2003 | 747 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2006 | 1929 | 0.070 |
Why?
|
| Tobacco Products | 1 | 2017 | 64 | 0.070 |
Why?
|
| Age of Onset | 1 | 2007 | 318 | 0.070 |
Why?
|
| Pregnancy | 2 | 2023 | 3046 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2009 | 1134 | 0.060 |
Why?
|
| Colpotomy | 1 | 2023 | 4 | 0.060 |
Why?
|
| Arousal | 2 | 2005 | 170 | 0.060 |
Why?
|
| Reference Values | 2 | 2016 | 662 | 0.050 |
Why?
|
| Adolescent | 3 | 2018 | 9345 | 0.050 |
Why?
|
| Forecasting | 1 | 2004 | 304 | 0.050 |
Why?
|
| Chi-Square Distribution | 2 | 2004 | 358 | 0.050 |
Why?
|
| Iliac Artery | 1 | 2022 | 41 | 0.050 |
Why?
|
| Algorithms | 1 | 2010 | 1913 | 0.050 |
Why?
|
| Blood Loss, Surgical | 1 | 2022 | 116 | 0.050 |
Why?
|
| Pelvic Floor | 1 | 2022 | 85 | 0.050 |
Why?
|
| Prostatic Neoplasms | 1 | 2012 | 1747 | 0.050 |
Why?
|
| Regression Analysis | 2 | 2012 | 591 | 0.040 |
Why?
|
| Dilatation | 1 | 2020 | 48 | 0.040 |
Why?
|
| Logistic Models | 1 | 2004 | 1214 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2024 | 584 | 0.040 |
Why?
|
| Smartphone | 1 | 2020 | 41 | 0.040 |
Why?
|
| Chicago | 1 | 2004 | 1434 | 0.040 |
Why?
|
| Registries | 1 | 2023 | 808 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2022 | 424 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 2360 | 0.040 |
Why?
|
| Inappropriate Prescribing | 1 | 2018 | 19 | 0.040 |
Why?
|
| Urination Disorders | 1 | 2018 | 50 | 0.040 |
Why?
|
| Internet | 1 | 2020 | 323 | 0.040 |
Why?
|
| Endoscopy | 1 | 2020 | 352 | 0.030 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2016 | 12 | 0.030 |
Why?
|
| Psychopharmacology | 1 | 2006 | 26 | 0.030 |
Why?
|
| Diagnostic Techniques, Urological | 1 | 2016 | 14 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2022 | 2497 | 0.030 |
Why?
|
| Behavior | 1 | 2006 | 85 | 0.030 |
Why?
|
| Models, Psychological | 1 | 2006 | 158 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2016 | 205 | 0.030 |
Why?
|
| Linear Models | 1 | 2016 | 422 | 0.030 |
Why?
|
| Social Environment | 1 | 2005 | 187 | 0.030 |
Why?
|
| Self Report | 1 | 2016 | 297 | 0.030 |
Why?
|
| Remission, Spontaneous | 1 | 2003 | 52 | 0.030 |
Why?
|
| Isometric Contraction | 1 | 2003 | 42 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2016 | 281 | 0.030 |
Why?
|
| Hand Strength | 1 | 2003 | 52 | 0.030 |
Why?
|
| Patient Admission | 1 | 2003 | 114 | 0.030 |
Why?
|
| Speech | 1 | 2003 | 85 | 0.030 |
Why?
|
| Personality Assessment | 1 | 2003 | 97 | 0.030 |
Why?
|
| Choice Behavior | 1 | 2004 | 161 | 0.030 |
Why?
|
| Biotransformation | 1 | 2002 | 49 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 798 | 0.030 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2002 | 131 | 0.020 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2012 | 69 | 0.020 |
Why?
|
| Psychometrics | 1 | 2003 | 330 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2002 | 667 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2002 | 506 | 0.020 |
Why?
|
| Sex Factors | 1 | 2003 | 1075 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 2769 | 0.020 |
Why?
|
| Biopsy | 1 | 2012 | 1184 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 1732 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 5358 | 0.020 |
Why?
|